GO:1902073 positive regulation of hypoxia-inducible factor-1alpha signaling pathway: Oxygen-Sensing Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902073 describes any process that activates or increases the frequency, rate or extent of hypoxia-inducible factor-1alpha (HIF-1alpha) signaling, a central oxygen-sensing pathway.
• HIF-1alpha protein stabilization under low oxygen is the canonical mechanism of positive regulation, and pharmacological activators such as DMOG can mimic this effect.
• Positive regulation of HIF-1alpha signaling influences macrophage polarization, angiogenesis, metabolism, autophagy and cell survival in diverse disease contexts [1,2,7,8].
• Dysregulated HIF-1alpha signaling is implicated in periodontitis, lung cancer progression, diabetic kidney disease, immune thrombocytopenia and oxygen-induced retinopathy [1,2,3,4,5,7].
• Key genes in this process include HIF1A, VHL, EGLN1 (PHD2), ARNT, EPAS1, and downstream effectors such as HMOX1, PYGL and BECN1-related autophagy regulators [3,6,8].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of positive regulators of HIF-1alpha signaling in human cells and animal models.
Description
The Gene Ontology term GO:1902073, positive regulation of hypoxia-inducible factor-1alpha signaling pathway, defines any biological process that activates or increases the frequency, rate or extent of signaling through hypoxia-inducible factor-1alpha (HIF-1alpha). HIF-1alpha is a transcription factor that mediates adaptive responses to low oxygen, and its positive regulation is essential for cellular survival, metabolic reprogramming and tissue homeostasis under hypoxia [1,7]. This term captures both the stabilization of HIF-1alpha protein and the enhancement of its downstream transcriptional activity. Researchers study GO:1902073 because HIF-1alpha signaling is a central node in cancer, inflammation, ischemia and metabolic disease. For example, pharmacological activation of HIF-1alpha by DMOG inhibits alveolar bone resorption in murine periodontitis by modulating macrophage polarization. In lung cancer, chronic stress promotes protumor macrophage polarization and tumor progression through HIF-1alpha-related mechanisms. Positive regulation of HIF-1alpha signaling also protects renal tubular epithelial cells from ferroptosis via the HIF-1alpha/HMOX1 axis in diabetic kidney disease. These findings underscore the importance of understanding how HIF-1alpha signaling is upregulated at the molecular level. This article integrates authoritative QuickGO annotation with verified PubMed literature to provide a research-grade overview of GO:1902073, its mechanisms, key genes, disease relevance and experimental methods, including CRISPR-based models for functional validation.
positive regulation of hypoxia-inducible factor-1alpha signaling pathway At A Glance
| GO ID | GO:1902073 |
|---|---|
| GO term | positive regulation of hypoxia-inducible factor-1alpha signaling pathway |
| Ontology | biological_process |
| Synonym | activation of HIF1alpha pathway; hypoxic stabilization of HIF1A; upregulation of hypoxia-inducible factor-1alpha signaling pathway |
| Definition | Any process that activates or increases the frequency, rate or extent of hypoxia-inducible factor-1alpha signaling pathway. |
| Major function | Enhances HIF-1alpha protein stability and transcriptional activity in response to hypoxia or pharmacological activators. |
| Related cellular component | Cytoplasm, nucleus, and HIF-1alpha transcriptional complex. |
| Related molecular function | Protein stabilization, DNA binding, transcription coactivation. |
| Disease relevance | Cancer, periodontitis, diabetic kidney disease, immune thrombocytopenia, retinopathy. |
What Is GO:1902073?
GO:1902073 is a biological process term defined as any process that activates or increases the frequency, rate or extent of hypoxia-inducible factor-1alpha signaling pathway. In practice, this includes mechanisms that stabilize HIF-1alpha protein under hypoxia, enhance its nuclear translocation, promote its dimerization with ARNT, or amplify its transcriptional output. The term is synonymous with activation of HIF1alpha pathway, hypoxic stabilization of HIF1A, and upregulation of hypoxia-inducible factor-1alpha signaling, reflecting the multiple layers at which positive regulation can occur [1,3,8].
Why Is positive regulation of hypoxia-inducible factor-1alpha signaling pathway Important in Cell Biology?
Positive regulation of HIF-1alpha signaling is critically important because HIF-1alpha is a master regulator of oxygen homeostasis, and its upregulation drives adaptive responses that can be protective or pathological. In periodontitis, HIF-1alpha activation by DMOG inhibits alveolar bone resorption by modulating macrophage polarization. In cancer, chronic stress stimulates protumor macrophage polarization and lung cancer progression through HIF-1alpha-related pathways. In diabetic kidney disease, astragaloside IV mitigates ferroptosis via the HIF-1alpha/HMOX1 pathway in renal tubular epithelial cells. HIF-1alpha also regulates autophagy via the p27-E2F1 signaling pathway, and its downregulation contributes to impaired megakaryopoiesis in immune thrombocytopenia. These examples highlight the broad physiological and pathological significance of GO:1902073.
• Controls oxygen sensing and cellular adaptation to hypoxia [1,7].
• Modulates macrophage polarization and inflammation in periodontitis [1,4].
• Promotes tumor progression and protumor macrophage polarization in lung cancer.
• Protects renal tubular epithelial cells from ferroptosis in diabetic kidney disease.
• Regulates autophagy through p27-E2F1 signaling.
• Influences megakaryopoiesis and platelet production in immune thrombocytopenia.
• Drives metabolic reprogramming and epithelial-mesenchymal transition in pancreatic cancer.
• Contributes to oxygen-induced retinopathy in mice.
• Provides therapeutic targets for hypoxia-related diseases [1,3,4].
• Enables CRISPR-based functional genomics of HIF-1alpha pathway regulators.
What Happens During positive regulation of hypoxia-inducible factor-1alpha signaling pathway?
Oxygen-dependent stabilization of HIF-1alpha protein
In simple terms: When oxygen is low, the HIF-1alpha protein is protected from degradation and accumulates.
Under normoxia, HIF-1alpha is hydroxylated by prolyl hydroxylases and targeted for proteasomal degradation via the VHL E3 ubiquitin ligase. Positive regulation of HIF-1alpha signaling often involves inhibition of these hydroxylases or blockade of VHL-mediated degradation, leading to HIF-1alpha accumulation. Pharmacological activators such as DMOG inhibit prolyl hydroxylases and stabilize HIF-1alpha, as shown in murine periodontitis where DMOG inhibited alveolar bone resorption by regulating macrophage polarization. Hypoxic stabilization of HIF1A is a synonym for this GO term, reflecting the central role of protein stabilization.
Nuclear translocation and dimerization with ARNT
In simple terms: Stabilized HIF-1alpha moves into the nucleus and pairs with a partner protein to become active.
Once stabilized, HIF-1alpha translocates to the nucleus and dimerizes with aryl hydrocarbon receptor nuclear translocator (ARNT, also known as HIF-1beta). This heterodimer binds to hypoxia response elements (HREs) in target genes. Positive regulation can enhance this step by increasing HIF-1alpha nuclear import or ARNT availability. In oxygen-induced retinopathy, HIF-1alpha and survivin expression are elevated, suggesting enhanced nuclear activity. The transcriptional complex then drives expression of genes involved in angiogenesis, metabolism and survival.
Transcriptional activation of downstream target genes
In simple terms: The active HIF-1alpha complex turns on many genes that help cells survive low oxygen.
The HIF-1alpha/ARNT dimer activates transcription of target genes such as HMOX1, PYGL, and autophagy-related genes. In diabetic kidney disease, astragaloside IV mitigates ferroptosis through the HIF-1alpha/HMOX1 pathway in renal tubular epithelial cells. In pancreatic cancer, PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis, linking HIF-1alpha signaling to metabolic gene activation. HIF-1alpha also regulates autophagy via the p27-E2F1 signaling pathway, demonstrating the breadth of downstream effects.
Feedback regulation and crosstalk with other pathways
In simple terms: The pathway is tuned by feedback loops and interactions with other cellular signals.
Positive regulation of HIF-1alpha signaling is modulated by feedback mechanisms, including oxygen-dependent degradation and crosstalk with inflammatory and metabolic pathways. In immune thrombocytopenia, downregulation of HIF-1alpha contributes to impaired megakaryopoiesis, indicating that positive regulators are required for normal platelet production. Chronic stress stimulates protumor macrophage polarization to propel lung cancer progression, likely involving HIF-1alpha-dependent signaling in the tumor microenvironment. These examples illustrate that positive regulation is context-dependent and integrated with immune and metabolic signals.
Key Genes Involved in GO:1902073 positive regulation of hypoxia-inducible factor-1alpha signaling pathway
The following genes and proteins are central to positive regulation of HIF-1alpha signaling, based on verified literature and established pathway knowledge.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIF1A | Encodes HIF-1alpha, the master transcription factor stabilized under hypoxia | Core target for knockout, point mutation and overexpression studies [1,3,8] |
| VHL | E3 ubiquitin ligase that targets HIF-1alpha for degradation under normoxia | Loss-of-function mutations stabilize HIF-1alpha; key for knock-in models |
| EGLN1 (PHD2) | Prolyl hydroxylase that marks HIF-1alpha for VHL-mediated degradation | Pharmacological and genetic target for positive regulation |
| ARNT (HIF1B) | Dimerization partner for HIF-1alpha; required for DNA binding | Essential for transcriptional activity; knockout abolishes signaling |
| EPAS1 (HIF-2alpha) | Paralog of HIF-1alpha with overlapping and distinct targets | Comparative studies with HIF1A knockout |
| HMOX1 | Downstream target gene; heme oxygenase 1 | Mediates ferroptosis protection in diabetic kidney disease |
| PYGL | Glycogen phosphorylase; downstream metabolic target | Promotes EMT and metastasis in pancreatic cancer |
| BECN1 | Autophagy regulator; crosstalk with HIF-1alpha | Links HIF-1alpha to autophagy via p27-E2F1 |
| CDKN1B (p27) | Cell cycle inhibitor; mediates HIF-1alpha autophagy regulation | Key node in p27-E2F1 signaling |
| E2F1 | Transcription factor downstream of p27; regulates autophagy | Functional link to HIF-1alpha signaling |
| BIRC5 (Survivin) | Anti-apoptotic protein; co-regulated with HIF-1alpha | Elevated in oxygen-induced retinopathy |
| VEGFA | Angiogenesis factor; classical HIF-1alpha target | Readout of HIF-1alpha transcriptional activity |
| SLC2A1 (GLUT1) | Glucose transporter; HIF-1alpha target | Metabolic reprogramming readout |
| LDHA | Lactate dehydrogenase A; HIF-1alpha target | Glycolysis and metabolic adaptation |
| EPO | Erythropoietin; HIF-1alpha target | Hematopoiesis and oxygen delivery |
| TGFB1 | Cytokine crosstalk with HIF-1alpha in fibrosis | Context-dependent regulation |
| NFKB1 | Inflammatory transcription factor crosstalk | Links inflammation to HIF-1alpha [1,2] |
| STAT3 | Signal transducer; modulates HIF-1alpha expression | Immune and cancer signaling crosstalk |
How Is positive regulation of hypoxia-inducible factor-1alpha signaling pathway Regulated?
Positive regulation of HIF-1alpha signaling is controlled at multiple levels. Oxygen-dependent prolyl hydroxylation by EGLN1 (PHD2) and subsequent VHL-mediated ubiquitination provide the primary degradation switch; inhibition of these enzymes by hypoxia or pharmacological agents such as DMOG stabilizes HIF-1alpha. Transcriptional regulation of HIF1A mRNA, translational control, and post-translational modifications also contribute. Crosstalk with inflammatory pathways, including macrophage polarization, can enhance HIF-1alpha signaling in periodontitis and cancer [1,2]. In diabetic kidney disease, astragaloside IV upregulates the HIF-1alpha/HMOX1 axis to mitigate ferroptosis. Autophagy regulation via p27-E2F1 represents another layer of crosstalk. These mechanisms collectively determine the frequency, rate and extent of HIF-1alpha signaling.
positive regulation of hypoxia-inducible factor-1alpha signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIF1A | Periodontitis; macrophage polarization | Murine periodontitis model with DMOG treatment |
| HIF1A | Lung cancer; protumor macrophage polarization | Chronic stress mouse model of lung cancer |
| HIF1A/HMOX1 | Diabetic kidney disease; ferroptosis | Renal tubular epithelial cells treated with astragaloside IV |
| HIF1A | Immune thrombocytopenia; megakaryopoiesis | Megakaryocyte differentiation models |
| HIF1A/BIRC5 | Oxygen-induced retinopathy | Mouse model of oxygen-induced retinopathy |
Periodontitis and inflammatory bone loss
HIF-1alpha activation by DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization, suggesting that positive regulation of HIF-1alpha signaling is protective in this context. The HIF-1alpha axis also contributes to periodontitis pathogenesis, as reviewed in recent literature. These findings support targeting HIF-1alpha signaling for periodontal therapy.
Cancer progression and tumor microenvironment
Chronic stress stimulates protumor macrophage polarization to propel lung cancer progression, with HIF-1alpha signaling implicated in the tumor microenvironment. In pancreatic cancer, PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis, linking HIF-1alpha downstream metabolic activation to aggressive cancer phenotypes. Positive regulation of HIF-1alpha signaling can therefore support tumor growth and dissemination.
Diabetic kidney disease and ferroptosis
Astragaloside IV mitigates ferroptosis through the HIF-1alpha/HMOX1 pathway in renal tubular epithelial cells in diabetic kidney disease, indicating that positive regulation of HIF-1alpha signaling can protect against ferroptotic cell death. This highlights a therapeutic opportunity for HIF-1alpha activators in kidney disease.
Hematological and retinal disorders
Downregulation of HIF-1alpha contributes to impaired megakaryopoiesis in immune thrombocytopenia, suggesting that positive regulation is required for normal platelet production. In oxygen-induced retinopathy in mice, HIF-1alpha and survivin are elevated, linking positive regulation to pathological angiogenesis. HIF-1alpha also regulates autophagy via the p27-E2F1 signaling pathway, which may influence retinal and hematopoietic cell survival.
From positive regulation of hypoxia-inducible factor-1alpha signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase HIF-1alpha signaling? | CRISPR knockout in human cell lines (e.g., HEK293, HeLa) followed by HIF-1alpha reporter assay |
| Does a specific point mutation stabilize HIF-1alpha? | CRISPR point mutation knock-in of HIF1A or VHL in isogenic cell lines |
| Does a disease-associated variant affect HIF-1alpha target gene expression? | Knock-in of the variant using CRISPR, followed by RNA-seq |
| Where is HIF-1alpha localized under hypoxia? | Tagged knock-in of HIF1A with fluorescent or epitope tag |
| Does overexpression of a regulator enhance HIF-1alpha signaling? | CRISPR activation or cDNA overexpression in cell lines |
| Which genes regulate HIF-1alpha signaling in a genome-wide manner? | CRISPR library screening with HIF-1alpha reporter |
How to Study the positive regulation of hypoxia-inducible factor-1alpha signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify HIF-1alpha target genes after positive regulation |
| Proteomics | Protein expression and modifications | Discover pathway components and downstream effectors |
| HRE-luciferase reporter | HIF-1alpha transcriptional activity | Screen for positive regulators |
| Immunofluorescence | HIF-1alpha localization and expression | Assess nuclear translocation |
| CRISPR knockout screen | Gene requirement for HIF-1alpha signaling | Genome-wide discovery of regulators |
| CRISPR activation screen | Gene sufficiency to activate HIF-1alpha | Identify positive regulators |
| Autophagy flux assay | Autophagic activity | Link HIF-1alpha to autophagy |
| Metabolic flux analysis | Glycolysis and oxidative phosphorylation | Assess metabolic reprogramming |
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify genes and proteins whose expression changes upon positive regulation of HIF-1alpha signaling. For example, proteomic and lipidomic analysis revealed mechanisms underlying astragaloside IV mitigation of ferroptosis through the HIF-1alpha/HMOX1 pathway. These methods provide unbiased readouts of pathway activity.
Reporter assays and imaging
HIF-1alpha transcriptional activity can be measured using HRE-luciferase reporters. Imaging of tagged HIF-1alpha allows visualization of nuclear translocation and stabilization. In oxygen-induced retinopathy, immunohistochemistry revealed elevated HIF-1alpha and survivin expression.
Functional genomics with CRISPR screens
CRISPR knockout and activation screens coupled with HIF-1alpha reporters enable genome-wide discovery of positive regulators. These screens can identify novel genes that increase HIF-1alpha signaling under normoxia or hypoxia.
Metabolic and autophagy assays
Seahorse metabolic analysis, lactate measurements and autophagy flux assays can assess downstream consequences of HIF-1alpha activation, such as glycolysis and autophagy regulation via p27-E2F1 [6,8].
How CRISPR Can Be Used to Study GO:1902073 positive regulation of hypoxia-inducible factor-1alpha signaling pathway
Knockout
CRISPR knockout of candidate positive regulators (e.g., EGLN1, VHL) can stabilize HIF-1alpha and activate signaling, while knockout of HIF1A or ARNT abolishes it. These models are essential for causal inference in GO:1902073 research.
Point Mutation
Point mutations in HIF1A or VHL can mimic disease-associated variants or alter protein stability. CRISPR point-mutation knock-in allows isogenic comparison of signaling activity.
Knock-in
Knock-in of tagged HIF1A (e.g., GFP or HA) enables live-cell imaging and chromatin immunoprecipitation. Knock-in of reporter cassettes can quantify pathway activity.
Overexpression
CRISPR activation or cDNA overexpression of positive regulators can enhance HIF-1alpha signaling, useful for gain-of-function studies and therapeutic target validation.
How EDITGENE Supports positive regulation of hypoxia-inducible factor-1alpha signaling pathway Research
Researchers studying positive regulation of hypoxia-inducible factor-1alpha signaling pathway-related genes often need to determine whether a candidate gene is causally involved in stabilizing HIF-1alpha or enhancing its transcriptional output. EDITGENE provides comprehensive CRISPR services to generate knockout, point-mutation, knock-in and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional dissection of GO:1902073.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of hypoxia-inducible factor-1alpha signaling pathway research.
Frequently Asked Questions About positive regulation of hypoxia-inducible factor-1alpha signaling pathway
What is GO:1902073?
GO:1902073 is the Gene Ontology term for positive regulation of hypoxia-inducible factor-1alpha signaling pathway, defined as any process that activates or increases the frequency, rate or extent of HIF-1alpha signaling.
What genes are involved in positive regulation of HIF-1alpha signaling?
Key genes include HIF1A, VHL, EGLN1 (PHD2), ARNT, EPAS1, and downstream targets such as HMOX1, PYGL and BECN1 [1,3,6,8].
How is HIF-1alpha signaling positively regulated?
Positive regulation occurs through stabilization of HIF-1alpha protein, enhanced nuclear translocation, dimerization with ARNT, and increased transcriptional activity [1,3,8].
What diseases are associated with HIF-1alpha signaling?
HIF-1alpha signaling is implicated in periodontitis, lung cancer, diabetic kidney disease, immune thrombocytopenia and oxygen-induced retinopathy [1,2,3,5,7].
What is the role of DMOG in HIF-1alpha signaling?
DMOG is a HIF-1alpha activator that inhibits prolyl hydroxylases, stabilizing HIF-1alpha; it inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization.
How does HIF-1alpha regulate autophagy?
HIF-1alpha regulates autophagy via the p27-E2F1 signaling pathway, linking oxygen sensing to autophagic flux.
What experimental models are used to study GO:1902073?
CRISPR knockout, point-mutation, knock-in and overexpression cell models, as well as mouse models of periodontitis, cancer, kidney disease and retinopathy, are commonly used [1,2,3,7].
What is the HIF-1alpha/HMOX1 pathway?
The HIF-1alpha/HMOX1 pathway refers to HIF-1alpha-driven expression of heme oxygenase 1 (HMOX1), which protects renal tubular epithelial cells from ferroptosis in diabetic kidney disease.
How does chronic stress affect HIF-1alpha signaling in cancer?
Chronic stress stimulates protumor macrophage polarization to propel lung cancer progression, with HIF-1alpha signaling contributing to the tumor microenvironment.
What CRISPR services are available for studying HIF-1alpha signaling?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening and bioinformatics services to study positive regulation of HIF-1alpha signaling.
Conclusion
GO:1902073, positive regulation of hypoxia-inducible factor-1alpha signaling pathway, is a fundamental biological process that governs cellular adaptation to hypoxia and contributes to diverse diseases including periodontitis, cancer, diabetic kidney disease, immune thrombocytopenia and retinopathy [1,2,3,5,7]. Understanding its molecular mechanisms, key genes and regulatory layers provides opportunities for therapeutic intervention. CRISPR-based models and functional genomics are powerful tools to dissect this pathway and identify novel positive regulators.
References
- 1. Chen MH et al.. 2021. HIF-1α activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization.. Int Immunopharmacol 99:107901 PMID: 34273637
- 2. Liu C et al.. 2025. Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression.. Cancer Res 85(13):2429-2447 PMID: 40202818
- 3. Liu J et al.. 2024. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease.. J Ethnopharmacol 334:118517 PMID: 38972525
- 4. Fadl A et al.. 2026. The Contribution of the Hypoxia Inducible Factor-1α Axis to Periodontitis.. J Dent Res 105(6):707-716 PMID: 41851081
- 5. Qi J et al.. 2017. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.. Thromb Haemost 117(10):1875-1886 PMID: 28771276
- 6. Ji Q et al.. 2023. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer.. Int J Biol Sci 19(6):1894-1909 PMID: 37063425
- 7. Liu N et al.. 2014. Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.. Int J Clin Exp Pathol 7(10):6814-9 PMID: 25400763
- 8. Wang P et al.. 2017. Hypoxia inducible factor-1α regulates autophagy via the p27-E2F1 signaling pathway.. Mol Med Rep 16(2):2107-2112 PMID: 28627618
